Relay Therapeutics, Inc. (NASDAQ:RLAY) has 221 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 31 Dec, 2025 | 27,904,963 | 0 | 0.00% | $236,075,987.00 |
| Commodore Capital LP | 31 Dec, 2025 | 17,000,000 | 0 | 0.00% | $143,820,000.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 13,859,172 | -914,504 | -6.19% | $117,248,595.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 13,228,502 | -530,880 | -3.86% | $111,913,127.00 |
| Casdin Capital, LLC | 31 Dec, 2025 | 13,003,574 | 1,662,193 | 14.66% | $110,010,236.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 9,691,445 | 295,701 | 3.15% | $81,989,624.00 |
| Bellevue Group AG | 31 Dec, 2025 | 8,345,364 | -246 | 0.00% | $70,601,779.00 |
| State Street Corp | 31 Dec, 2025 | 6,426,111 | 1,360,121 | 26.85% | $54,364,899.00 |
| Nextech Invest, Ltd. | 31 Dec, 2025 | 4,701,506 | 855,097 | 22.23% | $39,774,741.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 3,719,268 | 1,850,397 | 99.01% | $31,465,006.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,409,363 | 354,777 | 11.61% | $28,849,082.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 3,220,186 | 1,409,835 | 77.88% | $27,242,774.00 |
| Spruce Street Capital LP | 31 Dec, 2025 | 2,984,125 | 2,984,125 | 0.00% | $25,245,698.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 2,480,350 | -2,600 | -0.10% | $20,983,096.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 2,232,451 | -50,229 | -2.20% | $18,886,535.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 2,099,912 | 924,941 | 78.72% | $17,765,256.00 |
| Morgan Stanley | 31 Dec, 2025 | 2,018,464 | 254,368 | 14.42% | $17,076,206.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 1,903,245 | 1,903,245 | 0.00% | $16,101,453.00 |
| Alphabet Inc. | 31 Dec, 2025 | 1,568,753 | 0 | 0.00% | $13,271,651.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,560,265 | 464,630 | 42.41% | $13,199,842.00 |